Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues

Endocrinology

Volumn 139, Issue 3, 1998, Pages 1082-1092

  Petersen, Donna N ^a   Tkalcevic, George T ^a   Koza Taylor, Petra H ^a   Turi, Tom G ^a   Brown, Thomas A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; GENE INSERTION; GENE SEQUENCE; HORMONE BINDING; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 0031791153     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.3.5840     Document Type: Article

References (43)

1. Lobo RA 1995 Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 173:982-989
2. Hammond CB 1996 Menopause and hormone replacement therapy, an overview. Obstet Gynecol 87:2S-15S
3. Paganini-Hill A 1995 The risks and benefits of estrogen replacement therapy: Leisure World. Int J Fertil Menopausal Stud 40:54-62
4. Schwartz J, Freeman R, Frishman W 1995 Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J Clin Pharmacol 35:1-16
5. Sherwin BB 1996 Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 87:20S-26S
6. Paganini-Hill A 1996 Oestrogen replacement therapy and Alzheimer's disease. Br J Obstet Gynaecol 103:80-86
7. Salamone LM, Pressman AR, Seeley DG, Cauley JA 1996 Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med 156:1293-1297
8. Denke MA 1996 Lipids, estrogen status, and coronary heart disease risk in women. Med Sci Sports Exerc 28:13-14
9. Jordan VC 1995 Studies on the estrogen receptor in breast cancer - 20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat 36:267-285
10. Sato M, Kim J, Short LL, Slemenda CW, Bryant HU 1995 Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. J Pharmacol Exp Ther 272:1252-1259
11. Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidsey-Frink KL, Ma YF, Jee WS, Thompson DD 1997 Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 20:31-39
12. Feldman D 1997 Estrogens from plastic - are we being exposed? Endocrinology 138:1777-1779
13. Zacharewski T 1997 In vitro bioassays for assessing estrogenic substances. Environ Sci Tech 31:613-623
14. Malayer JR, Gorski J 1993 An integrated model of estrogen receptor action. Dornest Anim Endocrinol 10:159-177
15. Parker MG, Arbuckle N, Dauvois S, Danielian P, White R 1993 Structure and function of the estrogen receptor. Ann NY Acad Sci 684:119-126
16. Korach KS 1994 Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527
17. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS 1995 Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9:1441-1454
18. Ogawa S, Lubahn DB, Korach KS, Pfaff DW 1997 Behavioral effects of estrogen receptor gene disruption in male mice. Proc Natl Acad Sci USA 94:1476-1481
19. Eddy EM, Washburn TF, Bunch DO, Goulding EH, Gladen BC, Lubahn DB, Korach KS 1996 Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137:4796-4805
20. Merchenthaler I, Shugrue PJ, Lubahn D, Negro-Vilar A, Korach KS, Estrogen responses in estrogen receptor-disrupted mice: an in vivo autoradiographic and in situ hybridization study. Program of the 10th International Congress of Endocrinology, San Francisco, CA, 1996, p 744 (Abstract)
21. Shughrue PJ, Komm B, Merchenthaler I 1996 The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids 61:678-681
22. Lubahn DB, Taylor JA, Das SK, Dey SK, Estrogen responses in the estrogen receptor-minus mouse. Program of the 10th International Congress of Endocrinology, San Francisco, CA, 1996, p 572 (Abstract)
23. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
24. Mosselman S, Polman J, Dijkema R 1996 ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
25. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V 1997 Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 11:353-365
26. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870
27. Katzenellenbogen BS, Korach KS 1997 A new actor in the estrogen receptor drama - enter ER-beta. Endocrinology 138:861-862
28. Williams D, Gorski J 1974 Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro. Biochemistry 13:5537-5542
29. Leake RE, Habib F 1987 Steroid hormone receptors: assay and characterization. In: Green B, Leake RE (eds) Steroid Hormones: A Practical Approach. IRL Press Ltd, Oxford, pp 67-92
30. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
31. Zhang QX, Hilsenbeck SG, Fuqua SA, Borg A 1996 Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol 59:251-260
32. Miksicek RJ, Lei Y, Wang Y 1993 Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res Treat 26:163-174
33. Pfeffer U 1996 Estrogen receptor mRNA variants. Do they have a physiological role? Ann NY Acad Sci 784:304-313
34. Fuqua SA, Wolf DM 1995 Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res Treat 35:233-241
35. Fuqua SA, Allred DC, Auchus RJ 1993 Expression of estrogen receptor variants. J Cell Biochem 17G:194-197
36. Murphy LC, Wang M, Coutt A, Dotzlaw H 1996 Novel mutations in the estrogen receptor messenger RNA in human breast cancers. J Clin Endocrinol Metab 81:1420-1427
37. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H 1996 A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct Biol 3:87-94
38. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-969
39. Berry M, Metzger D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818
40. Galien R, Evans HF, Garcia T 1996 Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol 10:713-722
41. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
42. Yang NN, Venugopalan M, Hardikar S, Glasebrook A 1996 Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxilene. Science 273:1222-1225
43. Smith CL, Nawaz Z, O'Malley BW 1997 Coactivator and compressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:657-666